feed,title,long_url,short_url
Benzinga,Optinose's XHANCE Meets Primary Endpoints In Chronic Sinusitis Trial,https://benzinga.com/general/biotech/22/03/26015975/optinoses-xhance-meets-primary-endpoints-in-chronic-sinusitis-trial,https://bit.ly/36Z1t5M
Benzinga,Carl Icahn Out Of Occidental As Warren Buffett Doubles Down,https://benzinga.com/news/22/03/26019780/carl-icahn-out-of-occidental-as-warren-buffett-doubles-down,https://bit.ly/3Mxbk3e
Benzinga,Merck's Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients,https://benzinga.com/general/biotech/22/03/26014939/mercks-keytruda-shows-improved-metastasis-free-survival-in-melanoma-patients,https://bit.ly/3vM8Vvl
Benzinga,Tonix Pharma Collaborates With Massachusetts General Hospital For TNX-1900 In Binge Eating Disorder,https://benzinga.com/general/biotech/22/03/26018680/tonix-pharma-collaborates-with-massachusetts-general-hospital-for-tnx-1900-in-binge-eating-disord,https://bit.ly/3Cn0Ej5
